201 related articles for article (PubMed ID: 19846180)
21. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
22. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
Kalaiarasi P; Kaviarasan K; Pugalendi KV
Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
[TBL] [Abstract][Full Text] [Related]
23. Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats.
Collier GR; Traianedes K; Macaulay SL; O'Dea K
Horm Metab Res; 1993 Jan; 25(1):9-12. PubMed ID: 8428713
[TBL] [Abstract][Full Text] [Related]
24. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats.
Zhang XF; Tan BK
Acta Pharmacol Sin; 2000 Dec; 21(12):1157-64. PubMed ID: 11603293
[TBL] [Abstract][Full Text] [Related]
25. Levels of plasma insulin, leptin and adiponectin, and activities of key enzymes in carbohydrate metabolism in skeletal muscle and liver in fasted ICR mice fed dietary n-3 polyunsaturated fatty acids.
Higuchi T; Shirai N; Saito M; Suzuki H; Kagawa Y
J Nutr Biochem; 2008 Sep; 19(9):577-86. PubMed ID: 17911005
[TBL] [Abstract][Full Text] [Related]
26. Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice.
Ishikawa Y; Watanabe K; Takeno H; Tani T
Arzneimittelforschung; 1998 Mar; 48(3):245-50. PubMed ID: 9553681
[TBL] [Abstract][Full Text] [Related]
27. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats.
Tan BK; Tan CH; Pushparaj PN
Life Sci; 2005 Apr; 76(24):2827-39. PubMed ID: 15808883
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters.
Jang EM; Choi MS; Jung UJ; Kim MJ; Kim HJ; Jeon SM; Shin SK; Seong CN; Lee MK
Metabolism; 2008 Nov; 57(11):1576-83. PubMed ID: 18940397
[TBL] [Abstract][Full Text] [Related]
29. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
Sahin K; Onderci M; Tuzcu M; Ustundag B; Cikim G; Ozercan IH; Sriramoju V; Juturu V; Komorowski JR
Metabolism; 2007 Sep; 56(9):1233-40. PubMed ID: 17697867
[TBL] [Abstract][Full Text] [Related]
30. Treatment with a melanocortin agonist improves abnormal lipid metabolism in streptozotocin-induced diabetic mice.
Leckstrom A; Lew PS; Poritsanos NJ; Mizuno TM
Neuropeptides; 2011 Apr; 45(2):123-9. PubMed ID: 21216462
[TBL] [Abstract][Full Text] [Related]
31. Antidiabetic and antioxidant potential of ethanolic extract of Butea monosperma leaves in alloxan-induced diabetic mice.
Sharma N; Garg V
Indian J Biochem Biophys; 2009 Feb; 46(1):99-105. PubMed ID: 19374261
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades.
Manna P; Sinha M; Sil PC
Chem Biol Interact; 2009 Oct; 181(3):297-308. PubMed ID: 19682444
[TBL] [Abstract][Full Text] [Related]
33. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
[TBL] [Abstract][Full Text] [Related]
34. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
Wang ZJ; Liu Q; Li PP; Zou CH; Shen ZF
Eur J Pharmacol; 2008 Feb; 580(1-2):277-83. PubMed ID: 18048028
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection.
Fukushima M; Hattori Y; Tsukada H; Koga K; Kajiwara E; Kawano K; Kobayashi T; Kamata K; Maitani Y
J Gene Med; 2007 Nov; 9(11):976-85. PubMed ID: 17868184
[TBL] [Abstract][Full Text] [Related]
36. Improving glycogenesis in Streptozocin (STZ) diabetic mice after administration of green algae Chlorella.
Cherng JY; Shih MF
Life Sci; 2006 Feb; 78(11):1181-6. PubMed ID: 16289560
[TBL] [Abstract][Full Text] [Related]
37. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice.
Jung UJ; Lee MK; Park YB; Jeon SM; Choi MS
J Pharmacol Exp Ther; 2006 Aug; 318(2):476-83. PubMed ID: 16644902
[TBL] [Abstract][Full Text] [Related]
38. [Alteration of polyol metabolism in glomeruli of streptozotocin diabetic rats--analysis by gas chromatography-mass spectrometry].
Wang LN; Fukui M; Tomino Y; Koide H
Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):401-8. PubMed ID: 2142967
[TBL] [Abstract][Full Text] [Related]
39. Effect of lipids from Erabu sea snake, Laticauda semifasciata, on plasma glucose, insulin, and adipocytokine concentrations of normal and streptozotocin-diabetic mice.
Shirai N; Higuchi T; Suzuki H; Shimizu E
Ann Nutr Metab; 2006; 50(5):425-32. PubMed ID: 16847395
[TBL] [Abstract][Full Text] [Related]
40. Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3.
Azevedo MF; Camsari C; Sá CM; Lima CF; Fernandes-Ferreira M; Pereira-Wilson C
Phytother Res; 2010 Jun; 24 Suppl 2():S220-4. PubMed ID: 20127879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
